Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5610679 | 0.72 | — | — | |
| SCHEMBL1110140 | 0.70 | — | — | |
| SCHEMBL1109984 | 0.70 | — | — | |
| SCHEMBL8197758 | 0.69 | TSHR (0.38) | — | |
| SCHEMBL712270 | 0.66 | — | — | |
| SCHEMBL4595567 | 0.64 | TSHR (0.33) | — | |
| Sulfuric Acid SCHEMBL2576524 | 0.64 | TP53 (0.44) | TP53 | |
| Sulfuric Acid SCHEMBL21195062 | 0.64 | TSHR (0.44) | TP53 | |
| SCHEMBL28814076 | 0.64 | — | — | |
| SCHEMBL2879940 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1253143-C | Method for treating hair | KAO CORP (JP) | 2006-04-26 | — | — | CN | disclosed |
| US-20040097728-A1 | Method for producing anellated tetrahydro-{1h}-triazoles | BASF AKTIENGESELLSCHAFT (DE) | 2004-05-20 | — | — | US | disclosed |
| US-6737544-B1 | HEATING ABOVE MELTING POINT | BASF AKTIENGESELLSCHAFT (DE) | 2004-05-18 | — | — | US | disclosed |
| EP-1393708-A1 | METHOD OF TREATING HAIR | Kao Corporation (JP) | 2004-03-03 | — | — | EP | disclosed |
| US-20040011373-A1 | Method of treating hair | KAO CORPORATION (JP) | 2004-01-22 | — | — | US | disclosed |
| CN-1463190-A | Method for treating hair | KAO CORP (JP) | 2003-12-24 | — | — | CN | disclosed |
| US-6150303-A | Substituted 3-phenylisoxazolines | BASF AKTIENGESELLSCHAFT (DE) | 2000-11-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040097728-A1 | Method for producing anellated tetrahydro-{1h}-triazoles | CBR1, CBR3, QSOX1 | TP53 4256/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.